Shenzhen NewDEL Biotech Co., Ltd.
News
-
Good news! NewDEL Biotech has been honored with the "Top 50 Innovative Enterprises in the Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology" award as a rising star company.
On December 28th, the 6th Guangdong-Hong Kong-Macao Greater Bay Area Biotechnolo
-
NewDEL Biotech successfully held the initiation meeting for the Phase I clinical study of small molecule ND-003!
On November 29, 2023, the inaugural center initiation meeting for the Phase I cl
-
NewDEL Biotech has been awarded the Top Ten Prize in the Final Round of the 8th Tsinghua Entrepreneurship & Innovation Competition!
On November 8, 2023, the final round of the 8th Tsinghua Alumni Entrepreneurship
-
【Hot Topic】NewDEL Biotech & Small Molecule Center's First Class I New Drug Granted Clinical Trial Approval!
Shenzhen NewDEL Biotech Co., Ltd. ("NewDEL Biotech") and Guangdong Innovation C
-
NewDEL Biotech was shortlisted in the 2022 ChinaVenture 50 "New Seed List" Top 150!
Recently, NewDEL Biotech stood out among over 3,000 companies and made it to the
-
Guangdong Innovation Center For Small Molecule Drug Discovery ("Small Molecule Center") and NewDEL Biotech jointly published a paper on molecular generation based on DEL.
Guangdong Innovation Center For Small Molecule Drug Discovery and NewDEL Biotech
-
NewDEL Biotech DEL+AI: Constructing efficient drug discovery models for complex drugs without or with minimal known active molecules as targets.
A major breakthrough in improving the success rate of new drug development is th
-
NewDEL Biotech appoints renowned medicinal chemist Dr. Nick Terrett as the company's scientific advisor.
Shenzhen NewDEL Biotech Co., Ltd.("NewDEL Biotech"）recently announced the appoin
-
NewDEL Biotech announces the completion of tens of millions of yuan in Pre-A round financing to accelerate the construction of the DEL3.0 technology platform and the layout of new drug pipelines.
Shenzhen NewDEL Biotech Co., Ltd. ("NewDEL Biotech"）recently announced the compl
-
NewDEL Biotech: Pioneering the proprietary DEL3.0 technology platform with independent intellectual property rights to address the innovation bottleneck at the source of new drug development.
China needs genuine innovative drugs! This is the insight gained by He Xun after
Shenzhen NewDEL Biotech Co., Ltd.
Contact: Mr. Lu Email：nd@newdel.com.cn
Telephone：+86-0755-28199301 Postal code： 518110
A1503 Building 1-A YESEN Intelligent Community,1301-76 Guanguang Rd.，Longhua Dist,Shenzhen,Guangdong,China
Copyright 2021-2022深圳市新樾生物科技有限公司版权所有 粤ICP备2022125782号
